MD News and Press, Mednax Inc. From 02/02/22

Mednax, Inc. (NYSE: MD) (“Mednax”) announced today the pricing of $400.0 million aggregate principal amount of 5.375% Senior Notes due 2030 (the “ Notes ”) in a private offering (the “ Offering ”) that is exempt from the registration req...

Mednax (NYSE:MD) to issue $400M in aggregate principal amount of senior notes due 2030 in a private offering. The proposed offering of notes is subject to market and other conditions. Net proceeds and other available funds, including cash on hand and proceeds from its credit agreement, t...

Mednax, Inc. (NYSE: MD) (“Mednax”) announced today that it is proposing to issue $400.0 million in aggregate principal amount of Senior Notes due 2030 (the “ Notes ”) in a private offering that is exempt from the registration requirements of the Securitie...

Mednax, Inc. (NYSE: MD) today announced that it will present on Tuesday, November 30, 2021 at 2:15 p.m. EST to investors attending Bank of America’s 2021 Leveraged Finance Conference, taking place virtually. The presentation will be broadcast through live audio webcasts. AB...

Jeffrey Smith's Starboard Value LP exits Spire Global (NYSE:SPIR), and boosts its eHealth (NASDAQ:EHTH) stake as well as a crop of SPACs, according to its 13F filing. Initiates position in Huntsman (NYSE:HUN) and Cyxtera Technologies (NASDAQ:CYXT). Cuts position in Papa John (NASDAQ:PZZA) and...

Mednax, Inc. (NYSE: MD) today announced that it will present on Wednesday, November 10, 2021 at 1:50 p.m. EST to investors attending Credit Suisse’s 30 th Annual Healthcare Conference, taking place virtually. The presentation will be broadcast through live audio webcasts. ...

Image source: The Motley Fool. MEDNAX, inc (NYSE: MD) Q3 2021 Earnings Call Oct 28, 2021 , 9:00 a.m. ET Operator Continue reading For further details see: MEDNAX, inc (MD) Q3 2021 Earnings Call Transcript

MEDNAX, Inc. (MD) Q3 2021 Earnings Conference Call October 28, 2021 09:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance & Strategy Mark Ordan - Chief Executive Officer Marc Richards - Chief Financial Officer Mack Hinson - President, Pediatrix and Obstetrix Medi...

Mednax (NYSE:MD): Q3 Non-GAAP EPS of $0.46 beats by $0.05; GAAP EPS of $0.37 beats by $0.05. Revenue of $493M (+7.0% Y/Y) beats by $12.96M. Press Release For further details see: Mednax EPS beats by $0.05, beats on revenue

Mednax, Inc. (NYSE: MD), the national medical group specializing in prenatal, neonatal, and pediatric services, today reported earnings from continuing operations of $0.37 per share for the three months ended September 30, 2021. On a non-GAAP basis, Mednax reported Adjusted EPS from con...